Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Cinisello Balsamo – page 191

2 955 clinical trials in Cinisello Balsamo, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Cinisello Balsamo at a glance
2 955
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 955 trials in Cinisello Balsamo

Open in trial search

Polycythaemia vera

Not recruiting

Study Comparing Givinostat and Hydroxyurea for Patients with High-Risk Polycythemia Vera

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Carbasalate Calcium
  • Sponsor:Italfarmaco S.p.A.

Study comparing giredestrant plus palbociclib versus letrozole plus palbociclib in patients with estrogen receptor-positive, HER2-negative advanced or metastatic breast cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Giredestrant
  • Sponsor:F. Hoffmann-La Roche AG

Hypophosphatasia

Not recruiting

Study on ALXN1850 for Adolescents and Adults with Hypophosphatasia Not Previously Treated with Asfotase Alfa

Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:ALXN1850
  • Sponsor:Alexion Pharmaceuticals Inc.

Study of Niraparib, Abiraterone Acetate, and Prednisone for Patients with Gene-Mutated Metastatic Castration-Sensitive Prostate Cancer

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Janssen Cilag International

Study of V940 and Pembrolizumab for Patients with High-Risk Muscle-Invasive Bladder Cancer After Surgery

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Merck Sharp & Dohme LLC

HIV infection

Not recruiting

Study on the Effects of VH4524184 for Adults Newly Diagnosed with HIV

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:VH4524184
  • Sponsor:Viiv Healthcare UK Limited

Hepatic cirrhosis

Not recruiting

Study on the Safety of Zibotentan and Dapagliflozin for Patients with Liver Cirrhosis

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:AstraZeneca AB

Study on Benralizumab and Mepolizumab for Patients with Eosinophilic Granulomatosis with Polyangiitis (EGPA) Receiving Standard Care

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Palbociclib
  • Sponsor:ETOP IBCSG Partners Foundation

Follicular lymphoma

Not recruiting

Study of Zanubrutinib and Obinutuzumab for Patients with Relapsed or Refractory Follicular Lymphoma

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Beigene Ltd.

Acute myeloid leukaemia+2

Not recruiting

Study on the Safety and Effectiveness of Quizartinib for Children and Young Adults with Acute Myeloid Leukemia (AML)

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Quizartinib Dihydrochloride
  • Sponsor:Daiichi Sankyo Inc.

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Cinisello Balsamo

What the registry says about research in the country

01 Mental Health Research

Innovative research focusing on Major Depressive Disorder with concurrent insomnia symptoms, evaluating new combination therapies alongside existing antidepressant treatments. Studies examine the effectiveness of adjunctive medications in improving depressive symptoms and sleep patterns.

  • Depression with Insomnia
  • Antidepressant Augmentation
  • Long-term Treatment Efficacy

Research aims to enhance treatment outcomes for patients who haven't responded adequately to conventional therapies.

02 Cardiovascular Studies

Advanced clinical research examining atherosclerotic cardiovascular disease prevention and treatment. Studies include innovative approaches to blood clot prevention in patients with irregular heartbeat who have undergone stent procedures.

  • Primary ASCVD Prevention
  • Anticoagulation Therapy
  • Post-PCI Treatment

Investigations focus on reducing major adverse cardiac events and improving patient outcomes.

03 Metabolic Disorders

Comprehensive studies targeting severe hypertriglyceridemia and related metabolic conditions. Multiple trials are evaluating new therapeutic approaches for managing elevated triglyceride levels and associated cardiovascular risks.

  • Triglyceride Management
  • Metabolic Disease Treatment
  • Cardiovascular Risk Reduction

Research focuses on developing effective treatments for patients with severe lipid disorders.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.